Valuation (59%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 28.05 | -7.75 |
| PEG Ratio (TTM) | -0.67 | -10.36 |
| P/S Ratio (TTM) | 0.90 | 2.67 |
| P/B Ratio (TTM) | 2.33 | 5.73 |
| P/FCF Ratio (TTM) | 3.75 | 39.55 |
| Price to 5YR AVG Earnings Ratio | -249.05 | 185.33 |
| Price to 5YR AVG FCF Ratio | 5.19 | -38.11 |
Profitability (30%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 1.20% | 1.20% |
| ROE (TTM) | 8.29% | -13.19% |
| Net Profit Margin (TTM) | 3.21% | 3.14% |
| ROIC 5YR AVG | 8.55% | -11.06% |
Growth (43%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 221.06% | -190.58% | -120.94% |
| Revenue | -11.31% | -1.52% | 0.16% |
| Net Income | 221.09% | -192.51% | -122.59% |
| Cash Flow | 31.42% | 4,174.09% | 2,505.70% |
Health (56%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 2.36 | 1.27 |
| Quick Ratio (TTM) | 2.31 | 1.17 |
| D/E Ratio (TTM) | 3.82 | 0.25 |
| Interest Coverage (TTM) | 2.97 | -12.73 |
| Piotroski F-Score | 9 | 6 |
| Altman Z-Score | 1.14 | 2.36 |
| LTL to 5YR AVG FCF | 8.83 | 19.06 |
| Shares Outstanding Growth 5YR AVG | -0.40% | 4.58% |